Utility of flow cytometry studies in the management of patients with multiple myeloma. Paiva B et al. Curr Opin Oncol. 2016 Sep 12. [Epub ahead of print]. Minimal residual disease evaluation in autologous stem cell transplantation recipients with multiple myeloma. Gupta R et al. Leuk Lymphoma. 2016 Sep 23:1-4. [Epub ahead of print]. Role of MRD status in relation to clinical outcomes in…
IFM (Intergroupe francophone du myélome) recommendations for uniform interpretation of serum and urine protein electrophoresis in multiple myeloma diagnosis and follow-up. Dejoie T et al. Ann Biol Clin (Paris). 2016 Aug 1;74(4):429-441. Application of PET/CT in treatment response evaluation and recurrence prediction in patients with newly-diagnosed multiple myeloma. Li Y et al. Oncotarget. 2016 Aug 19. doi: 10.18632/oncotarget.11418. [Epub ahead of print]. The independent…
Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis. Wei B et al. Onco Targets Ther. 2016 Jul 1;9:4015-22. doi: 10.2147/OTT.S102733. eCollection 2016. RGS1 expression is associated with poor prognosis in multiple myeloma. Roh J et al. J Clin Pathol. 2016 Jul 21. pii: jclinpath-2016-203713. doi: 10.1136/jclinpath-2016-203713. [Epub ahead of print]. Diagnostic performances of M-protein tests according to the clinical presentations…
Bone mineral density utilization in patients with newly diagnosed multiple myeloma. Muchtar E et al. Hematol Oncol. 2016 Jun 21. doi: 10.1002/hon.2303. [Epub ahead of print]. Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study. D’Souza A et al. Br J Haematol. 2016 Jun 13. doi: 10.1111/bjh.14170. [Epub ahead of print].…
Increased circulating VCAM-1 correlates with advanced disease and poor survival in patients with multiple myeloma: reduction by post-bortezomib and lenalidomide treatment. Terpos E et al. Blood Cancer J. 2016 May 27;6:e428. doi: 10.1038/bcj.2016.37. Clinical and prognostic utility of cardiovascular magnetic resonance imaging in myeloma patients with suspected cardiac amyloidosis. Bhatti S et al. Eur Heart J Cardiovasc Imaging. 2016 May 25. pii: jew101. [Epub…
Minimal residual disease monitoring and immune profiling using second generation flow cytometry in elderlymultiple myeloma. Paiva B et al. Blood. 2016 Apr 26. pii: blood-2016-03-705319. [Epub ahead of print]. Development and Validation of Electrochemiluminescence Assays to Measure Free and Total sSLAMF7 in Human Serum in the Absence and Presence of Elotuzumab. Postelnek J et al. AAPS J. 2016 Apr 26. [Epub…
Diagnostic Advances in Multiple Myeloma. Barley K et al. Curr Hematol Malig Rep. 2016 Feb 27. [Epub ahead of print]. Monokine induced by interferon gamma (MIG/CXCL9) is an independent prognostic factor in newly diagnosed myeloma. Bolomsky A et al. Leuk Lymphoma. 2016 Mar 21:1-10. [Epub ahead of print]. Myeloma bone and extra-medullary disease: Role of PET/CT and other whole-body imaging techniques. Rubini G et…
Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment. Nishihori T et al. Curr Hematol Malig Rep. 2016 Feb 22. [Epub ahead of print]. Fully automated classification of bone marrow infiltration in low-dose CT of patients with multiple myelomabased on probabilistic density model and supervised learning. Martínez-Martínez F et al. Comput Biol Med. 2016 Feb 8;71:57-66. doi: 10.1016/j.compbiomed.2016.02.001. [Epub ahead of print].…
Prospective comparison of conventional radiography, low-dose computed tomography and magnetic resonance imaging in monoclonal gammopathies. Minarik J et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Jan 5. doi: 10.5507/bp.2015.064. [Epub ahead of print]. Interference of daratumumab in monitoring multiple myeloma patients using serum immunofixation electrophoresis can be abrogated using the daratumumab IFE reflex assay (DIRA). van…
Imaging features of haematological malignancies of kidneys. Sandrasegaran K et al. Clin Radiol. 2015 Dec 11. pii: S0009-9260(15)00444-4. doi: 10.1016/j.crad.2015.11.007. [Epub ahead of print]. Minimal tumour burden in haematological diseases: a step forward with quantitative assessment of Bence-Jones in nephelometry? Pieri M et al. Br J Haematol. 2015 Dec 18. doi: 10.1111/bjh.13878. [Epub ahead of print]. ANNALS EXPRESS: Low IgA levels…